Abstract |
Inflammatory myofibroblastic tumor is an intermediate-grade neoplasm with potential for recurrence and rare metastasis. Rearrangement of the anaplastic lymphoma kinase gene with variable fusion partners and anaplastic lymphoma kinase expression using immunohistochemistry are noted in about half of the tumors. We present a hepatic inflammatory myofibroblastic tumor from a 34-year-old man with an unusual rearrangement between the Ran binding protein 2 and anaplastic lymphoma kinase genes, as well as a peculiar round cell transformation of tumor cells and a unique nuclear membrane expression of anaplastic lymphoma kinase protein. As the fourth reported inflammatory myofibroblastic tumor with this fusion so far, we find that these genetic and morphologic features may be related to a poor clinical outcome. The diagnostic difficulty and other prognostic factors of inflammatory myofibroblastic tumor are also discussed.
|
Authors | Sung-Ting Chen, Jen-Chieh Lee |
Journal | Human pathology
(Hum Pathol)
Vol. 39
Issue 12
Pg. 1854-8
(Dec 2008)
ISSN: 1532-8392 [Electronic] United States |
PMID | 18701132
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Biomarkers, Tumor
- Molecular Chaperones
- Nuclear Pore Complex Proteins
- ran-binding protein 2
- ALK protein, human
- Anaplastic Lymphoma Kinase
- Protein-Tyrosine Kinases
- Receptor Protein-Tyrosine Kinases
|
Topics |
- Adult
- Anaplastic Lymphoma Kinase
- Base Sequence
- Biomarkers, Tumor
(metabolism)
- Fatal Outcome
- Fibroblasts
(metabolism, pathology)
- Gene Rearrangement
- Hepatectomy
- Humans
- Immunohistochemistry
- Liver Neoplasms
(genetics, metabolism, pathology)
- Male
- Molecular Chaperones
(genetics, metabolism)
- Molecular Sequence Data
- Neoplasm Recurrence, Local
- Neoplasms, Muscle Tissue
(genetics, metabolism, pathology)
- Nuclear Pore Complex Proteins
(genetics, metabolism)
- Protein-Tyrosine Kinases
(genetics, metabolism)
- Receptor Protein-Tyrosine Kinases
- Reverse Transcriptase Polymerase Chain Reaction
|